• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Section Contents Menu

Newsroom

2008 Media Transcripts


Transcript for FDA’s Media Briefing: Guidance Document  --  Diabetes Mellitus, Evaluating Cardiovascular Risk and New Anti-diabetic Therapies to Treat Type II Diabetes

 

Transcript for FDA’s Media Briefing on the FDA’s Evaluation of Consumer Medication Information

 

Transcript of Partnership Between the Food & Drug Administration and WebMD

 

Transcript of FDA’s Updated Interim Safety and Risk Assessment of Melamine and its Analogues in Food for Humans

 

Transcript of Media Briefing on Pediatric Over-the-Counter Nonprescription Cough and Cold Products

 

Transcript of Media Briefing on Topical Drug Products Containing Papain and Ophthalmic Balanced Salt Solutions

 

Transcript of Media Briefing on FDA’s Draft Guidance for Industry on the Regulation of Genetically Engineered Animals

 

Transcript of Media Briefing on Ranbaxy Labs

 

Transcript of FDA Media Briefing on FDA's Safety Announcement Related to Four Drugs Known as TNF Blockers


Transcript of FDA Media Briefing on New Policies for Managing FDA Advisory Committees


Transcript of the Endocrinologic and Metabolic Drugs Advisory Committee Press Briefing


Transcripts of FDA Media Briefings on Salmonella Outbreak


Transcript of FDA Media Briefing on Safety Labeling Changes for Antipsychotic Drugs

 

Transcript for FDA Media Briefing on HFA-propelled Albuterol Inhalers


Transcript of FDA Media Briefing on Pregnancy and Lactation Labeling Proposal

Transcripts of FDA Press Conferences on Adverse Events Associated with Baxter Healthcare Corporation's Multiple-Dose Vials of Injectable Heparin


Transcript of FDA Press Conference on FDA’s Early Communication on Botox, Botox Cosmetic and Myobloc


Transcript of FDA Press Conference on President’s Budget for Fiscal Year 2009


Transcript of FDA Press Conference on Chantix


Transcript of FDA Press Conference on Early Communication about an Ongoing Review of Vytorin


Transcript of FDA Press Conference on Cough and Cold Medicine


Transcript of FDA Press Conference on Cloning Risk Assessment – Afternoon Media Telecon


Transcript of FDA Press Conference on FDA Announcement on Final Cloning Risk Assessment


Transcript of FDA Press Conference on FDA Actions on Bio-Identical Hormones